cfDNA sequencing enhances non-invasive early detection of gestational diabetes

Gestational diabetes mellitus (GDM) is a prevalent pregnancy complication posing significant health risks to both mothers and their newborns. Early detection and treatment of GDM are crucial to prevent adverse outcomes. Current screening methods, like glucose tolerance tests, are performed after 24 weeks of pregnancy and have limitations in patient compliance and accuracy.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup